Inixaciclib
Product Specifications
CAS Number
2370913-42-9
Synonyms
NUV-422
SKU
C01915-5mg
Target
CDK
Applications
Cell Cycle
Additionnal Information
Inixaciclib (NUV-422) is a potent inhibitor of CDK2, CDK4, and CDK6. It inhibits the growth of glioma cell lines in vitro and exhibits antitumor activity in GB xenograft models, PDX models of HR+ HER2- metastatic breast cancer resistant to CDK4/6 inhibitors and prostate cancer resistant to anti-androgens.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6168664-01 0.1 mL
STK3 (Serine/Threonine Kinase 3 (STE20 Homolog, yeast), FLJ90748, KRS1, MST2) (APC)
Sign In for Pricing
View Details 
MBS6168664-02 5x 0.1 mL
STK3 (Serine/Threonine Kinase 3 (STE20 Homolog, yeast), FLJ90748, KRS1, MST2) (APC)
Sign In for Pricing
View Details 
